An estimated 5 million adults and 1 million children used homeopathy in the past year. Those who practice it believe microscopic amounts of natural substances can stimulate natural healing.
In good news for Americans trying to quit smoking, a new product with international success will now be allowed for sale in the United States.
Tech innovators seeking to contribute in the new spheres need regulatory clarity and protection from outdated agency rules.
Scott Gottlieb is leaving the Food and Drug Administration. His successor needs the courage and determination to help millions of Americans stop smoking through less-harmful alternatives.
Letting medical research continue to advance is a great argument against single-payer health care. So Republicans should make it.
He believes the marijuana’s current classification inhibits research for medical advancements that include cannabis and cannabinoids.
Altria, the maker of Marlboro cigarettes, just bought a large stake in the e-cigarette company Juul. It’s good news for fans of vaping.
In 2009, the FDA looked the other way on a menthol ban. Now, they’re reconsidering it. Here’s a primer on two potential policy issues at play.
Tobacco has been a huge commercial success for 500 years. Can IQOS, a new high-tech product, really reduce smoking risks and transform the industry?
Every pro-life person should be concerned about the growing trend in easy-access abortion pills, delivered to your doorstep.
The American people can tell the difference between coconut and dairy milk without the help of Food and Drug Administration regulators, thanks.
The administration proposes changing the FDA’s name to the ‘Federal Drug Administration,’ making clear that its focus will solely be on drugs, devices, biologics, and tobacco.
Here’s a solution: stop focusing on trying to control prescription drug prices, and start paying attention to who’s paying them.
Reason Reporter Mike Riggs joins Federalist Radio to share the latest news and drug policy we are seeing from the new FDA commissioner.
The United Sates has never been a rich market for terrorists’ international tobacco trafficking. A new FDA policy will make it one.
Reason magazine’s science correspondent, Ronald Bailey, joins today’s Federalist Radio Hour to discuss bio, tech, and science issues.
The rising costs of many, if not all, medications are largely the result of the lack of competition in the pharmaceutical industry. That’s the FDA’s fault.
We could have increased access, improved quality, and decreased costs with better medical licensing, prescription drug regulation, Food and Drug Administration approval, and patent law.
A ‘landmark’ clinical trial finds parents could reduce by 80 percent a susceptible child’s risk of later developing a peanut allergy if they introduce peanut butter to their babies early.
While the public hold little sympathy for Big Pharma, when the drug industry suffers, people suffer. And when Big Pharma wins, people win.
- The 1519 Project: How Early Spanish Explorers Took Down A Mass-Murdering Indigenous CultFive hundred years ago, Hernando Cortez and his native continue reading >
- No, America Wasn’t Built On Slavery, But Faith That All Men Are Created EqualBy reframing America’s founding around slavery, the 1continue reading >
- The Political Perils Of Supporting IsraelLong before Donald Trump came around, conservative Jewscontinue reading >